Mounjaro vs Wegovy Prices.
Two headline treatments, one sensible question: which costs less? Here's the honest comparison — and where to see today's live prices for both.
Today's live prices.
Prices move daily, so the honest comparison is a live one:
The honest comparison.
Mounjaro (tirzepatide) and Wegovy (semaglutide) are the two most prescribed private weight-loss injections in the UK. They're made by different companies — Eli Lilly and Novo Nordisk — and priced independently by every pharmacy, which means the gap between them shifts week to week.
Historically, Wegovy's starting doses have tended to list lower than Mounjaro's, while higher maintenance doses can narrow or even reverse the gap — but "tended to" is doing a lot of work in that sentence. The only comparison worth trusting is today's, which is why we link you to live trackers rather than print a table that would age within days.
One thing price should never decide: which medicine you take. They work differently — tirzepatide targets GIP and GLP-1 receptors, semaglutide targets GLP-1 alone — and which suits you is a prescriber's call. The NHS evidence appraisals are NICE TA1026 (tirzepatide) and NICE TA875 (semaglutide) if you'd like the clinical detail.
The official sources, in one place.
These are the bodies that actually regulate, appraise and advise. If anything you read anywhere — including here — disagrees with them, believe them.